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Identification of ligand binding area of
Ste2p pheromone receptor in
Saccharomyces cerevisiae
Frank M. Mason
Senior Honors Project
Dr. Jeffrey M. Becker, Mentor

Abstra ct:
G-protein coupled receptors (GPCRs) are one of the largest families of cellular
receptors. With over 700 characterized in humans, GPCRs are responsible for sensing
pain, sight, and hundreds of other important functions. GPCRs constitute a significant
area of study, and even more importantly, recent estimates believe that over fifty percent
of drugs designed today target G-protein coupled receptors. Despite all of this interest,
much of GPCR structure is still yet unknown. Saccharomyces cerevisiae, more
commonly known as Baker's yeast, is a model organism for studying GPCRs. Ste2p is a
G-protein coupled pheromone receptor that binds a tridecapeptide, which is considered a
middle-sized ligand. Using site-directed mutagenesis, halo assays, and Western blots, an
area of four residues

(p55 G 56 V 57 R 58)

on the first transmembrane domain is identified as an

important area in Ste2p signaling and interaction with position 13 of a -factor.

Introduction :
Saccharomyces cerevisiae, commonly referred to as Baker's yeast, is a sexual
organism that initiates a mating pathway via pheromone-receptor interaction. Two
opposite mating types, MATa and MATa, interact with receptors expressed on cells of
opposite mating types to conjugate and mate. Cell surface receptors on these types
receive diffusible peptide signals from the opposite mating type to induce a response.
Ste2p is a G-protein coupled receptor on the surface of MATa. It binds the peptide signal
from MATa: WHWLQLKPGQPMY or a -factor. Through a G-protein mediated
response, the MATa will fuse with the MATa.
The G-protein coupled receptor of MATa, Ste2p, and its cognate ligand, a-factor,
is a model for GPCR-ligand interaction. GPCRs are a very broad family of proteins in

many organisms, especially in humans. GPCRs bind an extracellular signal. which causes
a change of conformation in the membrane, and transduces a signal to intracellular
mediators that affect the state of the cell. They are diverse in their ligands and in location
in different tissues and cell types. Due to their ubiquitous nature, they are an important
target of drug and therapeutic devices. The interaction between a-factor and Ste2 p may
help elucidate a clearer structural and functional relationship that could lead lo novel
treatments and therapies.
In this study, using analogs of a-factor have allowed for a clearer understanding
between the receptor-ligand interactions. In particular, photoreactive analogs allow for
cross-linking or covalent bonding between a-factor and Ste2p to further elucidate a
particular binding site or active site on the receptor, creating a more precise map of the
GPCR-ligand interaction.

Materials and Methods:
Organisms: S. cerevisiae LMI02 [Mata FUSJ-lacZ::URA3, lrpl , ura3, his-/, leu2, barf,
sle2LJI , mell] was used in halo assays because it lacks Barlp, the protease that cleaves a -

factor.
R

S. cerevisiae BJS21 [Mata ste2::Kan , prcl-407, pep4-3, leu2, tl'pl, ura 3-52] strain

transformed with pNED [STE2] (plasmid containing STE2 gene) was used in membrane
preparation and cross-linking studies.
Growth Arrest (Halo) Assay: Solid ML T media [yeast nitrogen base without amino
acids (Difco), 6.7 giL; casamino acids (Difco), 10 giL; glucose, 20g/L; adenine sulfate,

0.058 giL; arginine, 0.026 giL; asparagines, 0.058 giL; aspartic acid, 0.14 giL; glutamic
acid, 0.14 giL, histidine, 0.028 giL; isoleucine, 0.028 giL; leucine, 0.083 giL; lysine,

0.042 giL; methionine, 0.028 giL; phenylalanine, 0.69 giL; serine, 0.52 gi L ; threonine,

0.28g/L; tyrosine, 0.042 gi L; valine, 0.21 giL; and uracil, 0.028 giL] was overlaid with 4
6

mL of S. cerevisiae LMI02 cell suspension (5.0 x 10 cells/mL of Noble agar). Filter
disks (sterile blanks from Difco), 8 mm in diameter, were impregnated with 10
portions of peptide solutions at concentrations of 0.25 f.lg/f.lL, 0.125
~lgl ~lL,

0.03125

~lgl

f.lL, 0.0 156

~lgl

f.lL, 0.0078 f.lgl

~lL,

0.0039

~lgl ~lL,

~lgl ~lL

~lL

0.0625

and placed onto

the overlay. The plates were incubated at 30°C for 24-36 hours and then observed for
zones of clearing or halos around the disks. The data were expressed as the diameter of
the halo including the diameter of the disk. All assays were carried out in duplicate with
no more than a 2 mm variation in halo size at a particular amount applied for each
peptide.
Membrane preparation : S. cerevisiae strain BJS21pNED was harvested in bottles (3000

rpm, 15 minutes) and combined pellets. Determine packed cell volume and resuspend in
2 volumes of buffer with protease inhibitors [50 mM HEPES; 5 mM EDTA; PMSF, 1.7
f.lg/mL ; leupeptin, 1 ~lg/mL; pepstatin A, 1 f.lg/mL; pH 7.5]. Keep on ice. Add

resuspended cells to Braun homogenizer bottles about 113 full of acid washed (50% nitric
acid) glass beads. Rinse beads thoroughly with water and buffer before use and check pH
to verify that it is close to pH 7.5. Add about 25 mLs of cells per bottle. Homogenize at
low speeds with Braun homogenizer at cold temperature, 7 x 2 minute burst. Allow
bottles to coolon ice between bursts for about 2 minutes at 4°C. Collect homogenate into
50 mL tubes and wash beads with 2 mLs buffer plus inhibitors. Spin at 700x g (1800
rpm) at 4°C for 30 minutes to pellet debris and unbroken cells. Collect supernatant and
spin at in SW28 rotor at 25,000 rpm, 1 hour at 4°C to collect membrane fraction.

Resuspend membrane pellet in 4-5 volumes of 50 mM HEPES plus 20% glycerol plu s
protease inhibitors. Determine protein concentration via Bradford Assay.
Anti-Flag Immunoblot: Run SDS-Page gel (10%) and transfer blot onto Immobilon P

membrane. Incubate in blocking solution [5% milk in TBS; or 5% BSA in 1: 1
TBS:TBST] at room temperature for a minimum of 1 hour. Incubate overnight at 4°C in
primary antibody diluted 1:50,000 in TBST [10 mM Tris; 150 mM NaCl; 0.1 % Tween20; pH 7.5]. Wash 2x 5 minutes with blocking solution, then Ix 5 minutes with TBST,
then Ix 5 minutes with TBS [10 mM Tris; 150 mM NaCl; pH 7.5]. Incubate in secondary
antibody (anti-Rabbit-HRP) diluted 1:30,000 in TBST for 3 hours at room temperature.
Wash 3x 5' in blocking solution, 2x 5' in TBST, 2x 5' in TBS. Apply ECL
chemiluminescent detection system as directed for 5'. Remove blot from ECL reagents
and place on saran wrap and expose blot to film in dark room for varied amounts of time
and develop using machine.
NA-HRP Immunoblots : Run 10% SDS-Page gel and transfer onto Immobilon P.

Incubate membrane in blocking solution for 1-2 hours at room temperature. Briefly rinse
3 times with TBS. Incubate in NeutrAvidin HRP (Pierce) (1 :30,000 in TBST) OIN at
4°C. Wash 3x 5' in blocking solution. Wash 2x 5' in TBST. Wash 2x 5' in TBS. Develop
blot with ECL chemiluminescent detection system. Immediately before LIse, mix
detection reagents 1 and 2 in a 1: 1 ration. Transfer blots to a clean container, pour
detection reagent on the surface and incubate for 1 minute. Remove blots from detection
reagent and drain briefly. Wrap blot in plastic wrap and place face down against film in
dark room. Develop using developer machine.

Crosslinking of [Bpa 13]a-factor and partial purification of intact XL Ste2p:
BJS21pNED membranes (220 flg) were incubated with 975 ofPPBi (with 0.1 % BSA) in
siliconized microfuge tubes (Midwest Scientific) for 10 minutes at room temperature.
[Bpa I3 ]a-factor was added to the membranes and reaction was incubated for 2 hours at
room temperature with gentle mixing. The reaction mixture was aliquoted into three
wells of 24 well Costar culture plate (Cat# 3526) preblocked with PPBi (0.1 % BSA).
Separation of the reaction mixtures into the separate wells kept the depth of the samples
low (- 2 mm) for efficient UV penetration of the sample. The samples were held at 4°C
by placing on a prechi lled enzyme caddy and surrounded with ice. The samples were
irradiated without the culture plate lid at 365 1U11 for varied times at a distance of 12 cm in
a Stratalinker (Stratagene, La Jolla, CA). Membrane samples were recombined in
siliconized microfuge tubes and washed twice by centrifugation (J 4,000x g) with PPBi
(0.1 % BSA). Membrane pellets were dissolved in 2X sample buffer [0.25M Tris-HCI , pH
8.8; 0.005% bromphenol blue; 5% glycerol; 1.25%

~-mercaptoethanol ;

2% SDS].

Samples were heated to 37°C for 10 minutes and separated by SDS-Page (10% gel;
30mA). For subsequent receptor digestion analysis, the gel was exposed to a
phosphorimager screen (STORM, Molecular Dynamics) and the band of radioactivity
responding to the Ste2 p was excised and placed into dialysis tubing (15,000 MWCO)
with buffer [0. 2M Tris acetate (pH 7.4); 1.0% SDS; 100 mM dithiothreitoll.
Electroelution was performed by placing dialysis tubing containing the gcl in a horizontal
electrophoresis chamber (34 cm(L) x 21 cm(W) x 10 cm(D)) containing running buffer
[50 mM Tris acetate (pH 7.4); 0.1 % SDS; 0.5 mM sodiw11 thiogylcolateJ. Elution was
carried out at 100 volts for three hours. The buffer in the dialysis tubing was transferred

to a Millipore Ultrafree-1S centrifuge fllter device (30,000 ,WCO) and concentrated by
centrifugation. Concentrated sample was washed three times wit h50 mM Tris-RCl (pH
7.5).

Results:
Halo Assay: Halo assays are used to determine the biological activity of the receptors. In
this experiment, Cagdas Son of the Becker lab generated 9 site-directed mutants, and
their activity was compared to the wi ld type activity of the Ste2p receptor. The graph
displays relationship between the concentrations of a-factor and the halo size. To
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a halo size for each linear regression. The halo sizes of the
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The biological activity assay showed that most of the
73%
G56A
mutants elicited the same biological activity as the wild type.
108%
V57A

linearize the results, the log of the concentration was taken. An

Only the F55A, F55A/R58A, and G56A showed a significant decrease in activ ity. This
indicates that these residues are important in the activation of the Ste2p receptor. It
should be noted R58A mutant has almost identical activity to wild type, but the
F55A/R58A double mutant has an activity

~ 58%

of the wild type.

Membrane p.'eparation and Ste2p presence: A membrane preparation was prepared

using five mutants: M54A, F55A, F55A/R58A, G56A, and R58C. A Bradford Assay was
performed to determine the protein concentration of the membranes. A Western blot was
performed to detect for the presence of Ste2p using a -Flag antibody (figure below to
left). The artifact band indicates a nonspecific signal, however, this band shows that the
lanes are equalJy loaded, due to similar band expression.
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Also, a Coomassie stain was performed on the same gel to show these lanes have equal
amounts of protein (data not shown). However, the Ste2p bands (~52 kDa) indicate
differential expression. Wild type was not run on this gel, but it would be expected to be
similar to the R58C mutant.
Crosslinking Experiment: The membranes from the previous experiment were then

incubated with an a-factor analog: WHWLQLK(biotinylcaproate)PGPNleBpa or
[Bpa 13]a-factor. The biotin tag at position 7 allows for detection of the cross-linked
peptide, and the Bpa molecule incorporated at position 13 allows for cross-linking to
13

adjacent proteins. Using the crosslinki ng procedure, [Bpa ]a-factor is bound to the Ste2p
..,.,

receptor. To detect the
~

presence of crosslinked
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used to detect the biotin
tag on [Bpa 13]a-factor (see figure below to right). Using the information from the last
blot that showed equal amow1ts of membranes expressed different levels of Ste2p,
approximately equal amounts ofXL-Ste2p were loaded into each lane. The blot indicates
that these mutants have differential crosslinking abi lities, with R58C having minimal
crosslinking and M54A, G56A, and F55A having relatively equal crosslinking.

D iscussion :
Ha lo Assay: indicated that all but three mutants (F55A, F55A/R58A, and G56A) have

simi lar biological activity to wi ld type. The F55A mutant indicates that the aromaticity
may be crucial in allowing for a stable structure before binding or allows for an

interaction with

yl 3

on a-factor. The fact that R58A mutant on its own does not have a

decreased affinity but the F55A1R58A double mutant has almost 50% activity of wild
type suggests that an interaction between the F55 and R58 might be necessary. It is
possible that a cation-pi interaction occurs between the two side chains. The G56A
mutant elicits a lower biological activity. This has been previously reported and is mainly
due to receptor dimerization (Overton el aI. , 2003).
Membrane Preparation and Ste2p presence: This experiment provided interesting
data. Surprisingly the mutants had differential Ste2p expression. This phenomenon is
difficult to explain, but could be attributed to possible degradation in some of the
mutants. There is also a possibility that the some of the mutants did not allow 1'01'
orientation in the proper conformation and were degraded. These experiments are
currently being repeated for confirmation.
Crosslinking Experiment: With approximately equal an10Lmts of Ste2p, the crosslinking
I3

experiment indicated that different mutants express different abilities of the [Bpa ]afactor. The F55A/R58A double mutant shows decreased ability for crosslinking, which
coincides with the halo assay data to indicate that these residues are important in the
Ste2p-a-factor interaction. The R58C mutant indicates that maybe the positive charge of
Arg is important in allowing for the ligand binding. Possibly the Arg-Phe interaction, as
previously discussed, may be more important. Further experiments sho uld be done,
especially with the R58A mutant to provide a more conclusive picture.

Conclusion :
Ste2p is a GPCR located on the cell surface of MATa S. cerevisiae and binds the a-factor
ligand from the MATa cell type. In this study , it was shown that the region of t'our

residues (F55G)6V57R58) on the first transmembrane domain of Ste2p is important in
ligand binding and signal transduction. In particular, the residue F

55

seems to be

imp0l1ant in the receptor-ligand interaction and more importantly the F

55

and R

58

interaction together. When the F 55 and R 58 are mutated to alanines there was a decrease in
biological activity and a decreased affinity in the crosslinking experiments, suggesting
that the cation-pi interaction between these two side chains might be important in
maintaining a stable conformation for interaction with a-factor.
With this new information on the structure and function of one GPCR and its
ligand, a more distinct delineation of the structure and function of the GPCR family is
available. More research is needed on this subject, but hopefull y this research will
provide more information on this very important and essential structure .
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